Evidence map›Paper›PMID 28317093›Full record

ArticleClinical and experimental immunology2017

Non-neutralizing epitopes induce robust hepatitis C virus (HCV)-specific antibody-dependent CD56

L Long, M Jia, X Fan, H Liang, J Wang, L Zhu, Z Xie, T Shen

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and experimental immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

L LongDepartment of Laboratory Medicine, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
M JiaState Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Center for AIDS/STD Control and Prevention, China CDC, Beijing, China.
X FanDepartment of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University, Beijing, China.
H LiangState Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Center for AIDS/STD Control and Prevention, China CDC, Beijing, China.
J WangPeking University People's Hospital, Peking University Hepatology Institute, Beijing, China.
L ZhuDepartment of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University, Beijing, China.
Z XieDepartment of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University, Beijing, China.
T ShenDepartment of Microbiology and Infectious Disease Center, School of Basic Medical Sciences, Peking University, Beijing, China.ORCID 0000-0002-1365-9862
Peking University · CNNational Center for AIDS/STD Control and Prevention,China CDC · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural killer (NK) cell-mediated antibody-dependent cellular cytotoxicity (NK-ADCC) is of considerable interest in viral infection. However, little is known about NK-ADCC responses in chronic hepatitis C virus (HCV) infection. In this study, impaired non-specific antibody-dependent CD56

Indexed as

AdultAntibodies, ViralAntibody-Dependent Cell CytotoxicityCase-Control StudiesEpitopesFemaleHepacivirusHepatitis C, ChronicHumansInterferon-gammaKiller Cells, NaturalMaleMiddle AgedAntibodies, ViralEpitopesIFNG protein, humanInterferon-gammaantibody-dependent cellular cytotoxicityepitopehepatitis C virusnatural killer cellnon-neutralizing antibody

Identifiers

PMID28317093
PMCPMC5461086
OpenAlexW2610584151

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.